Comparison of time to positive and colony counting in an early bactericidal activity study of anti-tuberculosis treatment

International Journal of Tuberculosis and Lung Disease

Volumn 17, Issue 11, 2013, Pages 1448-1451

  Bark, Charles M ^a   Gitta, P ^b   Ogwang, S ^b,c   Nsereko, M ^b   Thiel, B A ^a   Boom, W H ^a   Eisenach, K D ^d   Joloba, M L ^e   Johnson, J L ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c JOINT CLINICAL RESEARCH CENTRE   (Uganda)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e MAKERERE UNIVERSITY   (Uganda)

Author keywords

Colony forming unit; EBA; MGIT; TB

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ARTICLE; BACTERIAL COUNT; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; CULTURE MEDIUM; FEASIBILITY STUDY; FEMALE; HUMAN; LUNG TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SOUTH AFRICA; SPUTUM CULTURE; SPUTUM SMEAR; STANDARDIZATION; TUBERCULOSIS CONTROL; UGANDA;

ADULT; ANTITUBERCULAR AGENTS; AUTOMATION, LABORATORY; COLONY COUNT, MICROBIAL; DRUG MONITORING; DRUG THERAPY, COMBINATION; ETHAMBUTOL; FEASIBILITY STUDIES; FEMALE; HUMANS; ISONIAZID; MALE; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PYRAZINAMIDE; RIFAMPIN; SPUTUM; TIME FACTORS; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; UGANDA; YOUNG ADULT;

EID: 84888081001     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.13.0063     Document Type: Article

References (19)

1. Diacon A H, Dawson R, von Groote-Bidlingmaier F, et al. 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial. Lancet 2012; 380: 986-993.
2. Donald P R, Diacon A H. The early bactericidal activity of anti-tuberculosis drugs: a literature review. Tuberculosis (Edinb) 2008; 88 (Suppl 1): S75-S83.
3. Jindani A, Dore C J, Mitchison D A. Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days. Am J Respir Crit Care Med 2003; 167: 1348-1354. (Pubitemid 36609718)
4. Rustomjee R, Lienhardt C, Kanyok T, et al. A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. Int J Tuberc Lung Dis 2008; 12: 128-138. (Pubitemid 351212403)
5. Diacon A H, Maritz J S, Venter A, et al. Time to detection of the growth of Mycobacterium tuberculosis in MGIT 960 for determining the early bactericidal activity of antituberculosis agents. Eur J Clin Microbiol Infect Dis 2010; 29: 1561-1565.
6. Diacon A H, Maritz J S, Venter A, van Helden P D, Dawson R, Donald P R. Time to liquid culture positivity can substitute for colony counting on agar plates in early bactericidal activity studies of antituberculosis agents. Clin Microbiol Infect 2012; 18: 711-717.
7. Bark C M, Okwera A, Joloba M L, et al. Time to detection of Mycobacterium tuberculosis as an alternative to quantitative cultures. Tuberculosis (Edinb) 2011; 91: 257-259.
8. Pheiffer C, Carroll N M, Beyers N, et al. Time to detection of Mycobacterium tuberculosis in BACTEC systems as a viable alternative to colony counting. Int J Tuberc Lung Dis 2008; 12: 792-798. (Pubitemid 351976711)
9. Bark C M, Thiel B A, Johnson J L. Pretreatment time to detection of Mycobacterium tuberculosis in liquid culture is associated with relapse after therapy. J Clin Microbiol 2012; 50: 538.
10. Hesseling A C, Walzl G, Enarson D A, et al. Baseline sputum time to detection predicts month two culture conversion and relapse in non-HIV-infected patients. Int J Tuberc Lung Dis 2010; 14: 560-570.
11. Epstein M D, Schluger N W, Davidow A L, Bonk S, Rom W N, Hanna B. Time to detection of Mycobacterium tuberculosis in sputum culture correlates with outcome in patients receiving treatment for pulmonary tuberculosis. Chest 1998; 113: 379-386. (Pubitemid 28110014)
12. Weiner M, Prihoda T J, Burman W, et al. Evaluation of time to detection of Mycobacterium tuberculosis in broth culture as a determinant for end points in treatment trials. J Clin Microbiol 2010; 48: 4370-4376.
13. Diacon A H, Dawson R, du Bois J, et al. Phase II dose-ranging trial of the early bactericidal activity of PA-824. Antimicrob Agents Chemother 2012; 56: 3027-3031.
14. Diacon A H, Dawson R, Hanekom M, et al. Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients. Int J Tuberc Lung Dis 2011; 15: 949-954.
15. Diacon A H, Dawson R, Hanekom M, et al. Early bactericidal activity and pharmacokinetics of PA-824 in smear-positive tuberculosis patients. Antimicrob Agents Chemother 2010; 54: 3402-3407.
16. Laszlo A, ed. Technical guide: sputum examination for tuberculosis by direct microscopy in low income countries. 5th ed. Paris, France: International Union Against Tuberculosis and Lung Disease, 2000.
17. Blumberg H M, Burman W J, Chaisson R E, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America. Treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167: 603-662.
18. Jindani A, Aber V R, Edwards E A, Mitchison D A. The early bactericidal activity of drugs in patients with pulmonary tuberculosis. Am Rev Respir Dis 1980; 121: 939-949. (Pubitemid 10118376)
19. Singer J D, Willett J B. Applied longitudinal data analysis: modeling change and event occurrence. Oxford, UK: Oxford University Press, 2003.